APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-Acting Growth Hormone(LAGH)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Long-Acting Growth Hormone(LAGH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025193 pages

Choose your research edition.

Industry ResearchLong-Acting Growth Hormone(LAGH) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-Acting Growth Hormone(LAGH) Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Long-Acting Growth Hormone(LAGH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-Acting Growth Hormone(LAGH) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-Acting Growth Hormone(LAGH) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Long-Acting Growth Hormone(LAGH) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Long-Acting Growth Hormone(LAGH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Long-Acting Growth Hormone(LAGH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-Acting Growth Hormone(LAGH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Long-Acting Growth Hormone(LAGH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-Acting Growth Hormone(LAGH) include Eli Lilly, GeneScience Pharmaceuticals, Pfizer, Anhui Anke Biotechnology, Sandoz International, Novo Nordisk, Merck Serono, LG Life Sciences and Ipsen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Long-Acting Growth Hormone(LAGH) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Long-Acting Growth Hormone(LAGH) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Long-Acting Growth Hormone(LAGH) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Long-Acting Growth Hormone(LAGH) market size, projected growth trends, production technologies, key applications, and end-use industries.

Long-Acting Growth Hormone(LAGH) Segment by Company

Eli Lilly

GeneScience Pharmaceuticals

Pfizer

Anhui Anke Biotechnology

Sandoz International

Novo Nordisk

Merck Serono

LG Life Sciences

Ipsen

Ferring Pharmaceuticals

F. Hoffmann-La Roche

Long-Acting Growth Hormone(LAGH) Segment by Type

Powder

Solvent

Long-Acting Growth Hormone(LAGH) Segment by Application

Prader Willi Syndrome

SHOX Deficiency

Chronic Renal Insufficiency

Growth Hormone Deficiency (GHD)

Turner Syndrome

Small for Gestational Age(SGA)

Others

Long-Acting Growth Hormone(LAGH) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Growth Hormone(LAGH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Acting Growth Hormone(LAGH) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Growth Hormone(LAGH).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Long-Acting Growth Hormone(LAGH) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Long-Acting Growth Hormone(LAGH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Long-Acting Growth Hormone(LAGH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Long-Acting Growth Hormone(LAGH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Long-Acting Growth Hormone(LAGH) Industry Trends Table 2. Long-Acting Growth Hormone(LAGH) Industry Drivers Table 3. Long-Acting Growth Hormone(LAGH) Industry Opportunities and Challenges Table 4. Long-Acting Growth Hormone(LAGH) Industry Restraints Table 5. Global Long-Acting Growth Hormone(LAGH) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Long-Acting Growth Hormone(LAGH) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Manufacturers Table 9. Global Long-Acting Growth Hormone(LAGH) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Long-Acting Growth Hormone(LAGH) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Long-Acting Growth Hormone(LAGH) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Long-Acting Growth Hormone(LAGH) Manufacturers, Product Type & Application Table 13. Global Long-Acting Growth Hormone(LAGH) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Long-Acting Growth Hormone(LAGH) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Table 17. Major Manufacturers of Solvent Table 18. Global Long-Acting Growth Hormone(LAGH) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Long-Acting Growth Hormone(LAGH) Sales by Type (2021-2026) & (K Units) Table 20. Global Long-Acting Growth Hormone(LAGH) Sales by Type (2027-2032) & (K Units) Table 21. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Type (2021-2026) Table 22. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Type (2027-2032) Table 23. Global Long-Acting Growth Hormone(LAGH) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Long-Acting Growth Hormone(LAGH) Revenue by Type (2021-2026) & (K Units) Table 25. Global Long-Acting Growth Hormone(LAGH) Revenue by Type (2027-2032) & (K Units) Table 26. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Type (2021-2026) Table 27. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Prader Willi Syndrome Table 29. Major Manufacturers of SHOX Deficiency Table 30. Major Manufacturers of Chronic Renal Insufficiency Table 31. Major Manufacturers of Growth Hormone Deficiency (GHD) Table 32. Major Manufacturers of Turner Syndrome Table 33. Major Manufacturers of Small for Gestational Age(SGA) Table 34. Major Manufacturers of Others Table 35. Global Long-Acting Growth Hormone(LAGH) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Long-Acting Growth Hormone(LAGH) Sales by Application (2021-2026) & (K Units) Table 37. Global Long-Acting Growth Hormone(LAGH) Sales by Application (2027-2032) & (K Units) Table 38. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Application (2021-2026) Table 39. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Application (2027-2032) Table 40. Global Long-Acting Growth Hormone(LAGH) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Long-Acting Growth Hormone(LAGH) Revenue by Application (2021-2026) & (K Units) Table 42. Global Long-Acting Growth Hormone(LAGH) Revenue by Application (2027-2032) & (K Units) Table 43. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Application (2021-2026) Table 44. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Application (2027-2032) Table 45. Global Long-Acting Growth Hormone(LAGH) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Long-Acting Growth Hormone(LAGH) Sales by Region (2021-2026) & (K Units) Table 47. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Region (2021-2026) Table 48. Global Long-Acting Growth Hormone(LAGH) Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Long-Acting Growth Hormone(LAGH) Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Long-Acting Growth Hormone(LAGH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2026) & (K Units) Table 52. North America Long-Acting Growth Hormone(LAGH) Sales by Country (2027-2032) & (K Units) Table 53. Europe Long-Acting Growth Hormone(LAGH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2026) & (K Units) Table 55. Europe Long-Acting Growth Hormone(LAGH) Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Long-Acting Growth Hormone(LAGH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Country (2027-2032) & (K Units) Table 62. Global Long-Acting Growth Hormone(LAGH) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Long-Acting Growth Hormone(LAGH) Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Long-Acting Growth Hormone(LAGH) Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Region (2021-2026) Table 66. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Region (2027-2032) Table 67. Eli Lilly Company Information Table 68. Eli Lilly Business Overview Table 69. Eli Lilly Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Eli Lilly Long-Acting Growth Hormone(LAGH) Product Portfolio Table 71. Eli Lilly Recent Development Table 72. GeneScience Pharmaceuticals Company Information Table 73. GeneScience Pharmaceuticals Business Overview Table 74. GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Portfolio Table 76. GeneScience Pharmaceuticals Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pfizer Long-Acting Growth Hormone(LAGH) Product Portfolio Table 81. Pfizer Recent Development Table 82. Anhui Anke Biotechnology Company Information Table 83. Anhui Anke Biotechnology Business Overview Table 84. Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Product Portfolio Table 86. Anhui Anke Biotechnology Recent Development Table 87. Sandoz International Company Information Table 88. Sandoz International Business Overview Table 89. Sandoz International Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sandoz International Long-Acting Growth Hormone(LAGH) Product Portfolio Table 91. Sandoz International Recent Development Table 92. Novo Nordisk Company Information Table 93. Novo Nordisk Business Overview Table 94. Novo Nordisk Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Novo Nordisk Long-Acting Growth Hormone(LAGH) Product Portfolio Table 96. Novo Nordisk Recent Development Table 97. Merck Serono Company Information Table 98. Merck Serono Business Overview Table 99. Merck Serono Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Merck Serono Long-Acting Growth Hormone(LAGH) Product Portfolio Table 101. Merck Serono Recent Development Table 102. LG Life Sciences Company Information Table 103. LG Life Sciences Business Overview Table 104. LG Life Sciences Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. LG Life Sciences Long-Acting Growth Hormone(LAGH) Product Portfolio Table 106. LG Life Sciences Recent Development Table 107. Ipsen Company Information Table 108. Ipsen Business Overview Table 109. Ipsen Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ipsen Long-Acting Growth Hormone(LAGH) Product Portfolio Table 111. Ipsen Recent Development Table 112. Ferring Pharmaceuticals Company Information Table 113. Ferring Pharmaceuticals Business Overview Table 114. Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Portfolio Table 116. Ferring Pharmaceuticals Recent Development Table 117. F. Hoffmann-La Roche Company Information Table 118. F. Hoffmann-La Roche Business Overview Table 119. F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Product Portfolio Table 121. F. Hoffmann-La Roche Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Long-Acting Growth Hormone(LAGH) Distributors List Table 125. Long-Acting Growth Hormone(LAGH) Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Long-Acting Growth Hormone(LAGH) Product Image Figure 2. Global Long-Acting Growth Hormone(LAGH) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-Acting Growth Hormone(LAGH) Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-Acting Growth Hormone(LAGH) Sales (2021-2032) & (K Units) Figure 5. Global Long-Acting Growth Hormone(LAGH) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Long-Acting Growth Hormone(LAGH) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Image Figure 9. Solvent Image Figure 10. Global Long-Acting Growth Hormone(LAGH) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Long-Acting Growth Hormone(LAGH) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Type (2021-2032) Figure 13. Global Long-Acting Growth Hormone(LAGH) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Type (2021-2032) Figure 16. Prader Willi Syndrome Image Figure 17. SHOX Deficiency Image Figure 18. Chronic Renal Insufficiency Image Figure 19. Growth Hormone Deficiency (GHD) Image Figure 20. Turner Syndrome Image Figure 21. Small for Gestational Age(SGA) Image Figure 22. Others Image Figure 23. Global Long-Acting Growth Hormone(LAGH) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Long-Acting Growth Hormone(LAGH) Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Application (2021-2032) Figure 26. Global Long-Acting Growth Hormone(LAGH) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Application (2021-2032) Figure 29. North America Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Long-Acting Growth Hormone(LAGH) Sales Market Share by Country (2021-2032) Figure 31. U.S. Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Long-Acting Growth Hormone(LAGH) Sales Market Share by Country (2021-2032) Figure 36. Germany Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Long-Acting Growth Hormone(LAGH) Sales Market Share by Country (2021-2032) Figure 43. China Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales Market Share by Country (2021-2032) Figure 51. Brazil Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Long-Acting Growth Hormone(LAGH) Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Long-Acting Growth Hormone(LAGH) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Long-Acting Growth Hormone(LAGH) Revenue (2021-2032) & (US$ Million) Figure 62. North America Long-Acting Growth Hormone(LAGH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Long-Acting Growth Hormone(LAGH) Revenue (2021-2032) & (US$ Million) Figure 64. Europe Long-Acting Growth Hormone(LAGH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Long-Acting Growth Hormone(LAGH) Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Long-Acting Growth Hormone(LAGH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Long-Acting Growth Hormone(LAGH) Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Long-Acting Growth Hormone(LAGH) Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Solvent
Applications
  • Prader Willi Syndrome
  • SHOX Deficiency
  • Chronic Renal Insufficiency
  • Growth Hormone Deficiency (GHD)
  • Turner Syndrome
  • Small for Gestational Age(SGA)
  • Others
Companies covered
  • Eli Lilly
  • GeneScience Pharmaceuticals
  • Pfizer
  • Anhui Anke Biotechnology
  • Sandoz International
  • Novo Nordisk
  • Merck Serono
  • LG Life Sciences
  • Ipsen
  • Ferring Pharmaceuticals
  • F. Hoffmann-La Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Long-Acting Growth Hormone(LAGH) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Long-Acting Growth Hormone(LAGH) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Long-Acting Growth Hormone(LAGH) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Long-Acting Growth Hormone(LAGH) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Long-Acting Growth Hormone(LAGH) Market Dynamics
  1. 2.1 Long-Acting Growth Hormone(LAGH) Industry Trends
  2. 2.2 Long-Acting Growth Hormone(LAGH) Industry Drivers
  3. 2.3 Long-Acting Growth Hormone(LAGH) Industry Opportunities and Challenges
  4. 2.4 Long-Acting Growth Hormone(LAGH) Industry Restraints
3 Long-Acting Growth Hormone(LAGH) Market by Manufacturers
  1. 3.1 Global Long-Acting Growth Hormone(LAGH) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Long-Acting Growth Hormone(LAGH) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Long-Acting Growth Hormone(LAGH) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Long-Acting Growth Hormone(LAGH) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Long-Acting Growth Hormone(LAGH) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Long-Acting Growth Hormone(LAGH) Manufacturers, Product Type & Application
  7. 3.7 Global Long-Acting Growth Hormone(LAGH) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Long-Acting Growth Hormone(LAGH) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Long-Acting Growth Hormone(LAGH) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Long-Acting Growth Hormone(LAGH) Tier 1, Tier 2, and Tier 3
4 Long-Acting Growth Hormone(LAGH) Market by Type
  1. 4.1 Long-Acting Growth Hormone(LAGH) Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Solvent
  4. 4.2 Global Long-Acting Growth Hormone(LAGH) Sales by Type
  5. 4.2.1 Global Long-Acting Growth Hormone(LAGH) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Long-Acting Growth Hormone(LAGH) Sales by Type (2021-2032)
  7. 4.2.3 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Long-Acting Growth Hormone(LAGH) Revenue by Type
  9. 4.3.1 Global Long-Acting Growth Hormone(LAGH) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Type (2021-2032)
  11. 4.3.3 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Type (2021-2032)
5 Long-Acting Growth Hormone(LAGH) Market by Application
  1. 5.1 Long-Acting Growth Hormone(LAGH) Application Introduction
  2. 5.1.1 Prader Willi Syndrome
  3. 5.1.2 SHOX Deficiency
  4. 5.1.3 Chronic Renal Insufficiency
  5. 5.1.4 Growth Hormone Deficiency (GHD)
  6. 5.1.5 Turner Syndrome
  7. 5.1.6 Small for Gestational Age(SGA)
  8. 5.1.7 Others
  9. 5.2 Global Long-Acting Growth Hormone(LAGH) Sales by Application
  10. 5.2.1 Global Long-Acting Growth Hormone(LAGH) Sales by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Long-Acting Growth Hormone(LAGH) Sales by Application (2021-2032)
  12. 5.2.3 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Application (2021-2032)
  13. 5.3 Global Long-Acting Growth Hormone(LAGH) Revenue by Application
  14. 5.3.1 Global Long-Acting Growth Hormone(LAGH) Revenue by Application (2021 VS 2025 VS 2032)
  15. 5.3.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Application (2021-2032)
  16. 5.3.3 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Application (2021-2032)
6 Global Long-Acting Growth Hormone(LAGH) Sales by Region
  1. 6.1 Global Long-Acting Growth Hormone(LAGH) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Long-Acting Growth Hormone(LAGH) Sales by Region (2021-2032)
  3. 6.2.1 Global Long-Acting Growth Hormone(LAGH) Sales by Region (2021-2026)
  4. 6.2.2 Global Long-Acting Growth Hormone(LAGH) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Long-Acting Growth Hormone(LAGH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Long-Acting Growth Hormone(LAGH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Long-Acting Growth Hormone(LAGH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Long-Acting Growth Hormone(LAGH) Revenue by Region
  1. 7.1 Global Long-Acting Growth Hormone(LAGH) Revenue by Region
  2. 7.1.1 Global Long-Acting Growth Hormone(LAGH) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Region (2021-2026)
  4. 7.1.3 Global Long-Acting Growth Hormone(LAGH) Revenue by Region (2027-2032)
  5. 7.1.4 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Long-Acting Growth Hormone(LAGH) Revenue (2021-2032)
  8. 7.2.2 North America Long-Acting Growth Hormone(LAGH) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Long-Acting Growth Hormone(LAGH) Revenue (2021-2032)
  11. 7.3.2 Europe Long-Acting Growth Hormone(LAGH) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Long-Acting Growth Hormone(LAGH) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Long-Acting Growth Hormone(LAGH) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly
  2. 8.1.1 Eli Lilly Company Information
  3. 8.1.2 Eli Lilly Business Overview
  4. 8.1.3 Eli Lilly Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly Long-Acting Growth Hormone(LAGH) Product Portfolio
  6. 8.1.5 Eli Lilly Recent Developments
  7. 8.2 GeneScience Pharmaceuticals
  8. 8.2.1 GeneScience Pharmaceuticals Company Information
  9. 8.2.2 GeneScience Pharmaceuticals Business Overview
  10. 8.2.3 GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Portfolio
  12. 8.2.5 GeneScience Pharmaceuticals Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Long-Acting Growth Hormone(LAGH) Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Anhui Anke Biotechnology
  20. 8.4.1 Anhui Anke Biotechnology Company Information
  21. 8.4.2 Anhui Anke Biotechnology Business Overview
  22. 8.4.3 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Product Portfolio
  24. 8.4.5 Anhui Anke Biotechnology Recent Developments
  25. 8.5 Sandoz International
  26. 8.5.1 Sandoz International Company Information
  27. 8.5.2 Sandoz International Business Overview
  28. 8.5.3 Sandoz International Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz International Long-Acting Growth Hormone(LAGH) Product Portfolio
  30. 8.5.5 Sandoz International Recent Developments
  31. 8.6 Novo Nordisk
  32. 8.6.1 Novo Nordisk Company Information
  33. 8.6.2 Novo Nordisk Business Overview
  34. 8.6.3 Novo Nordisk Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novo Nordisk Long-Acting Growth Hormone(LAGH) Product Portfolio
  36. 8.6.5 Novo Nordisk Recent Developments
  37. 8.7 Merck Serono
  38. 8.7.1 Merck Serono Company Information
  39. 8.7.2 Merck Serono Business Overview
  40. 8.7.3 Merck Serono Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Serono Long-Acting Growth Hormone(LAGH) Product Portfolio
  42. 8.7.5 Merck Serono Recent Developments
  43. 8.8 LG Life Sciences
  44. 8.8.1 LG Life Sciences Company Information
  45. 8.8.2 LG Life Sciences Business Overview
  46. 8.8.3 LG Life Sciences Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LG Life Sciences Long-Acting Growth Hormone(LAGH) Product Portfolio
  48. 8.8.5 LG Life Sciences Recent Developments
  49. 8.9 Ipsen
  50. 8.9.1 Ipsen Company Information
  51. 8.9.2 Ipsen Business Overview
  52. 8.9.3 Ipsen Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ipsen Long-Acting Growth Hormone(LAGH) Product Portfolio
  54. 8.9.5 Ipsen Recent Developments
  55. 8.10 Ferring Pharmaceuticals
  56. 8.10.1 Ferring Pharmaceuticals Company Information
  57. 8.10.2 Ferring Pharmaceuticals Business Overview
  58. 8.10.3 Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Portfolio
  60. 8.10.5 Ferring Pharmaceuticals Recent Developments
  61. 8.11 F. Hoffmann-La Roche
  62. 8.11.1 F. Hoffmann-La Roche Company Information
  63. 8.11.2 F. Hoffmann-La Roche Business Overview
  64. 8.11.3 F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Product Portfolio
  66. 8.11.5 F. Hoffmann-La Roche Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Long-Acting Growth Hormone(LAGH) Value Chain Analysis
  2. 9.1.1 Long-Acting Growth Hormone(LAGH) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Long-Acting Growth Hormone(LAGH) Production Mode & Process
  6. 9.2 Long-Acting Growth Hormone(LAGH) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Long-Acting Growth Hormone(LAGH) Distributors
  9. 9.2.3 Long-Acting Growth Hormone(LAGH) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst